Elevance Health (ELV) Income towards Parent Company (2009 - 2026)

Elevance Health (ELV) has reported Income towards Parent Company for 17 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Income towards Parent Company fell 16.63% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $4.9 billion (down 7.52% YoY), while the FY2025 annual figure was $5.7 billion, down 5.19% from the prior year.
• Income towards Parent Company fell to $1.5 billion in Q2 2026 per ELV's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Income towards Parent Company topped out at $2.3 billion in Q2 2024 and bottomed at $413.0 million in Q4 2024.
• Historically, Income towards Parent Company has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2022.
• Annual changes were most pronounced in 2024 — Income towards Parent Company plunged 50.3% — and 2025, when it surged 32.2%.
• Elevance Health's Income towards Parent Company stood at $877.0 million in 2022, then decreased by 5.25% to $831.0 million in 2023, then slumped by 50.3% to $413.0 million in 2024, then soared by 32.2% to $546.0 million in 2025, then jumped by 166.3% to $1.5 billion in 2026.
• Business Quant data shows ELV's Income towards Parent Company at $1.5 billion in Q2 2026, $1.8 billion in Q1 2026, and $546.0 million in Q4 2025.